## ROP: Roper Technologies, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 1.5% below STRENGTH zone (3.0-6.0%); PEG 1.96 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($428.74)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Neutral (Bullish: 1, Bearish: 1)

**1. 2,300 Shares in Roper Technologies, Inc. $ROP Acquired by Stance Capital LLC**
- Source: MarketBeat | 20251215T120853 | Neutral | Relevance: 100%
- Stance Capital LLC acquired 2,300 shares of Roper Technologies, Inc. (NASDAQ:ROP) valued at approximately $1,304,000 during the second quarter, as reported in their latest SEC filing. Other institutional investors like Vanguard Group Inc., Price T Rowe Associates Inc. MD, T. Rowe Price Investment Management Inc., State Street Corp, and Geode Capital Management LLC also adjusted their positions in the industrial products company. Analysts have provided mixed ratings for Roper Technologies, with a consensus of "Moderate Buy" and an average target price of $577.15, while insider transactions included both a significant sale by the CEO and a purchase by a director.

**2. Beck Mack & Oliver LLC Acquires 2,659 Shares of Roper Technologies, Inc. $ROP**
- Source: MarketBeat | 20251213T095105 | Somewhat-Bullish | Relevance: 100%
- Beck Mack & Oliver LLC recently increased its stake in Roper Technologies by 1.2% in Q2, acquiring 2,659 shares to hold a total of 226,438 shares, valued at approximately $128.35 million. This makes Roper Technologies the 17th largest position for the firm, accounting for 2.5% of its holdings. The company also announced an increased quarterly dividend of $0.91, and insiders, including CEO Laurence Hunn, have shown confidence by purchasing additional shares.

**3. Goldman Sachs Adjusts Roper Technologies Price Target to $507 From $572, Maintains Neutral Rating**
- Source: marketscreener.com | 20251216T125453 | Somewhat-Bearish | Relevance: 100%
- Goldman Sachs has revised its price target for Roper Technologies (ROP) to $507, down from $572, while retaining a Neutral rating on the stock. This adjustment comes amidst other analyst actions, with Barclays also recently lowering its price target for Roper Technologies to $475 from $506, maintaining an Underweight rating. The company's stock was trading at $443.60, down 0.51% at market close on December 15, 2025.

**4. Returns On Capital At Roper Technologies (NASDAQ:ROP) Have Stalled**
- Source: Yahoo Finance | 20251215T110853 | Bearish | Relevance: 100%
- Roper Technologies (NASDAQ:ROP) has shown stagnant returns on capital employed (ROCE) over the past five years, consistently earning 6.9%. Despite reinvesting in the business, increasing capital employed by 48%, these investments have not yielded higher returns. This indicates a potential issue for investors seeking multi-bagger stocks, as the company's performance has been lackluster.

**5. Roper Technologies, Inc. $ROP Shares Sold by The Manufacturers Life Insurance Company**
- Source: MarketBeat | 20251213T132914 | Somewhat-Bullish | Relevance: 100%
- The Manufacturers Life Insurance Company decreased its stake in Roper Technologies (NASDAQ:ROP) by 4.9% in Q2, now holding 336,942 shares valued at $190.99 million. Despite this, institutional investors collectively own 93.31% of the shares. Roper Technologies reported strong financial results, beating EPS estimates, increasing revenue by 14.3%, and raising its quarterly dividend to $0.91 per share, while insiders also bought shares, indicating confidence.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Barclays | $475 | $506 | -6% |
| 2025-11-20 | Piper Sandler | $600 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Barclays | main | Underweight |
| 2025-11-20 | Piper Sandler | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 3 ($2.47M) |
| Sells | 2 ($0.77M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+1.8%)
- Blackrock Inc.: 8.6% (-2.1%)
- State Street Corpora: 4.7% (+0.9%)
- Morgan Stanley: 3.7% (+6.8%)
- JPMORGAN CHASE & CO: 3.0% (+225.1%)

### Key Risks

1. Long-term trend broken: trading 16.3% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +3.3% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.96 elevated, pricing in significant growth expectations. Forward P/E 20.5x stretched relative to 8% growth. Quality metrics strong (margin 20%). Analyst sentiment negative (1 target cuts vs 0 raises). Insider buying signal ($2.5M), management confidence. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $47.7B |
| Beta | 0.94 |
| 52W Range | $435.42 - $595.17 |
| Short Interest | 1.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.96 |
| Forward P/E | 20.5 |
| Current P/E | 22.3 |
| YoY Growth | 8.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -1.8% to 1.5% (+3.3% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.5pp (needs >3.0% for momentum thesis). MRS_5 at 1.5% confirms short-term momentum alignment. Below SMA200 (0.84x), long-term trend not supportive. MACD histogram positive (1.55), confirming momentum. RSI neutral at 42. OFD pattern: -SLH (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.47% (CS: 40) | Neutral |
| RSI_14 | 42.2 | Neutral |
| MACD Histogram | 1.55 | Bullish |
| vs SMA20 | 0.998x | Below |
| vs SMA50 | 0.956x | Below |
| vs SMA200 | 0.837x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $443.60
- **Stop Loss:** $428.74 (3.3% risk)
- **Target:** $458.46 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 67
- **Position Value:** $29,721.20
- **Portfolio %:** 29.72%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-29 (Est: $5.14)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.11 | $5.14 | +0.6% |
| 2025Q2 | $4.83 | $4.87 | +0.8% |
| 2025Q1 | $4.74 | $4.78 | +0.8% |
| 2024Q4 | $4.73 | $4.81 | +1.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*